
Iovance Biotherapeutics Stock Hits Day Low of $2 Amid Price Pressure
2025-10-30 19:27:10Iovance Biotherapeutics, Inc. faced a notable decline, with its stock reaching an intraday low of USD 2.00. The company has struggled recently, showing a 10.31% decrease over the past month and a 72.97% loss year-to-date, alongside negative financial metrics and reduced promoter confidence.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






